Management of Blood Pressure by Trivrit and Aragvadha Churna as daily mild laxative

"Study the effect of Nitya Virechana with Trivrit and Aragvadha Churna in the management of Stage 1 Essential Hypertension"

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022040

Enrollment

Registered

2019-11-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Group-B Aragvadha Churna (Cassia fistula Linn.): Group-B Aragvadha Churna Nitya Virechana Route - Oral Route Study Duration - 30 days Frequency -10 gms of Aragvadha Phalamajja Churna da

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex between the age group of 30-60 yrs will be selected. 2. Newly detected cases of Stage 1 Essential Hypertension will be selected. 3. Hypertension stage 1-SBP (130-139) or DBP (80-89) will be included for the study.

Exclusion criteria

Exclusion criteria: 1. Hypertension associated with: a. Cardio-vascular diseases b. Cerebro-vascular diseases c. Hypothyroidism d. Diabetes Mellitus (Type 1/ Type 2/ GDM) e. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Reduce in the symptoms and range of Blood pressureTimepoint: Six months	—

Secondary

Measure	Time frame
1. To study the effect of Nitya Virechana with Trivrit Churna on Systolic and Diastolic blood pressure. 2. To study the effect of Nitya Virechana with Aragvadha Churna on Systolic and Diastolic blood pressure. 3. To compare the effect of Nitya Virechana with Trivrit and Aragvadha Churna on Systolic and Diastolic blood pressure. Timepoint: Six months	—

Countries

India

Contacts

Public ContactDr Punam Sawarkar

Datta Meghe Institute of Medical Sciences (Deemed University)

drsuple.punam@gmail.com9860667023

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026